gene_symbol
CD3E
hgnc_id
HGNC:1674
binding_type
antigen recognition
cytotoxicity
NO
cytotoxicity_type
INDIRECT
cytotoxicity_mechanism
Elranatamab bridges CD3 on T cells to BCMA on myeloma cells, activating T cells to kill BCMA+ tumor cells via perforin/granzyme-mediated cytolysis; CD3+ T cells are not the killed cells.
enzyme_product
Off
epitope
Off
variant
Off
isoform
Off
hla_specific
Off
gated
Off
trial_id_tar_ref
drug_id_tar_ref
disease_id_tar_ref
nct_id_tar_ref
NCT06207799
disease_id_num_tar_ref
2019
drug_id_num_tar_ref
5416